LOU064 (blinded) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-06 in 5mo
ESTIMATED |
READOUT
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy,
Phase 3 · Chronic Spontaneous Urticaria |
NVS NOVARTIS AG | LOU064 (blinded) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|